Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

New Study Suggests Link Between Tocotrienol and Inhibition of Cancer Cell Proliferation - Anti-Angiogenic Activity
2006-03-14 - Carotech, Inc.




Edison, New Jersey, March 13th 2006 – According to researchers in Japan, “Tocotrienols, vitamin E compounds that have an unsaturated side chain with three double bonds, selectively inhibited the activity of mammalian DNA polymerase lambda (pol lambda) in vitro. Polymerases are involved in cellular DNA synthesis during cell replication.”

The researchers also showed that tocotrienols inhibited the proliferation of and formation of tubes by bovine aortic endothelial cells, with delta-tocotrienol having the greatest effect. “The isomer’s structure might be an important factor in the inhibition of pol lambda,” suggested Y. Mizushina and colleagues at the Kobe Gakuin University.

The study published in a recent issue of Biochemical and Biophysical Research Communication, 2006 (339), 949-955 suggests that tocotrienols may act as potent anti-cancer agents by inhibiting pol lambda and angiogenesis.

What is interesting is that the regular tocopherols (alpha, beta, gamma and delta-tocopherol) do not influence the activities of mammalian polymerase and angiogenesis at all, suggesting that the three double bonds in the unsaturated side chain of tocotrienols play an important factor in the inhibition of polymerase lambda.

“Since angiogenesis is essential for tumour growth, its strong inhibition by tocotrienols but not tocopherols, could very well provide us with a safe dietary means to prevent a cancer from becoming metastatic,” says WH Leong, Vice President for Carotech Inc, the largest producer of Tocomin® full spectrum palm tocotrienol complex in the world.

Carotech Inc, is a wholly owned subsidiary of Carotech Bhd, Malaysia. Carotech, a public listed company in Malaysia (Malaysian Securities Exchange Board under the high-technology / high growth, MESDAQ Board), is the largest producer of tocotrienol in the world via its patented technology. Carotech Bhd is a subsidiary of Hovid Bhd., one of the largest GMP-certified pharmaceutical companies in Malaysia. For more information about Tocomin®, visit www.carotech.net or www.tocotrienol.org. Tocomin® is a registered trademark of Carotech Inc and protected by US Patent : 5,157,132

 

Advertisement



Sponsored Links: Featured Links:
 

NPIcenter Address and Phone Number
Contact Us | Privacy Policy | Terms of Use | Advertise
New Hope Natural Media

 

SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon